Articles Big Lie Big Pharma Black Projects Bodily Autonomy Catastrophe Censorship Centers For Disease Control Children Civil Disobedience Civil Rights Cognitive Dissonance Consciousness Coronavirus / COVID-19 Corporations Corruption Crimes Crimes Against Humanity Crony Capitalism Direct Actions Divide And Conquer DNA / mRNA Injection Doctors Domestic Terrorism Drug Pushers Dumb Us Down Economics Education Elderly Eugenics Fear Food And Drug Administration Forced DNA / mRNA Injection Frauds Freedom And Liberty Gaslighting Germ Theory vs. Terrain Theory Globalists Government Hate Crimes Health History Inalienable Rights Infertility Informed Consent Journalism Laws Lobbyists Lockdowns Longevity Medical Pfizer Political Propaganda Psychology Satanic Science Slavery Soul Surveillance Technology Theft They Live Totalitarianism Unvaccinated Vaccine Passports Vaccine Shedding VAERS War Whistleblowers World Health Organization

Did Pfizer Fail To Perform Industry Standard Animal Testing Prior To Initiation Of mRNA Clinical Trials? by TrialSite Staff

TrialSite has learned of material information regarding mRNA vaccine safety revealed by a freedom of information act (FOIA) request filed by a group of Canadian physicians. These doctors have become concerned about COVID-19 mRNA vaccine safety. This new safety information involves the Pfizer mRNA-based vaccine known as BNT162b2 or “Comirnaty.” The FOIA documents reveal animal study results demonstrating that the Pfizer mRNA-based vaccine does not remain at the injection site, but rather appears to spread widely after injection. According to the documents, pre-clinical studies show that the active part of the vaccine (mRNA-lipid nanoparticles), which produce the spike protein, spreads throughout the body and is then concentrated in various organs, including the ovaries and spleen. The FOIA-produced data sets are incomplete, so the full meaning of these data cannot be determined at this time. TrialSite has also learned via regulatory documents that apparently (at least in their European Medicines Agency submission), Pfizer did not follow industry-standard quality management practices during preclinical toxicology studies during vaccines, as key studies did not meet good laboratory practice (GLP). The full panel of industry-standard reproductive toxicity and genotoxicity studies were apparently also not performed. But does this matter in light of the risk-benefit analysis associated with regulatory emergency use authorization (EUA)?
https://trialsitenews.com/did-pfizer-fail-to-perform-industry-standard-animal-testing-prior-to-initiation-of-mrna-clinical-trials

Select a Donation Option (USD)

Enter Donation Amount (USD)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.